| scholarly article | Q13442814 |
| P50 | author | Valerie Beral | Q4793379 |
| Mark Lathrop | Q6768494 | ||
| Richard Peto | Q441534 | ||
| Million Women Study Collaborators | Q73545466 | ||
| Gillian K Reeves | Q73562500 | ||
| Ruth Travis | Q86575888 | ||
| Krys Baker | Q90743238 | ||
| Sarah J Tipper | Q114783784 | ||
| Diana Zelenika | Q30248012 | ||
| P2093 | author name string | Jane Green | |
| John Bell | |||
| Diana Bull | |||
| P2860 | cites work | Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. | Q37369631 |
| Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer | Q37438789 | ||
| Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies | Q43963634 | ||
| Birth weight, breast cancer susceptibility loci, and breast cancer risk | Q45296276 | ||
| Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women | Q46323110 | ||
| FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan. | Q51627790 | ||
| A common coding variant in CASP8 is associated with breast cancer risk | Q57250674 | ||
| Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer | Q57251792 | ||
| Genome-wide association study identifies novel breast cancer susceptibility loci | Q24645441 | ||
| Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study | Q24684767 | ||
| The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group | Q24791125 | ||
| Moderate alcohol intake and cancer incidence in women | Q28236401 | ||
| A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer | Q28303909 | ||
| Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease | Q30665466 | ||
| Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses | Q30695250 | ||
| A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). | Q34085748 | ||
| Breast cancer and hormone-replacement therapy in the Million Women Study | Q34223870 | ||
| Epidemiology of breast cancer. | Q34570046 | ||
| Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer | Q34631785 | ||
| MAP3Ks as central regulators of cell fate during development | Q34853182 | ||
| Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases | Q36465283 | ||
| Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis | Q37135273 | ||
| Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women | Q37292711 | ||
| Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. | Q37356243 | ||
| P433 | issue | 9732 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 2143-2151 | |
| P577 | publication date | 2010-06-03 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study | |
| P478 | volume | 375 |
| Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q91736468 | A novel metadherinΔ7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFĸB-SIRT3 axis |
| Q88442135 | A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk |
| Q34472668 | Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium |
| Q30872137 | Alcohol and breast cancer: reconciling epidemiological and molecular data |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q44012419 | Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk |
| Q33724850 | Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women |
| Q35913571 | Association of three SNPs in TOX3 and breast cancer risk: Evidence from 97275 cases and 128686 controls |
| Q34201805 | Breast Cancer Risk - Genes, Environment and Clinics |
| Q36393157 | Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women |
| Q36545335 | Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study |
| Q64461507 | Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan |
| Q35952548 | Breastfeeding and Immunohistochemical Expression of ki-67, p53 and BCL2 in Infiltrating Lobular Breast Carcinoma |
| Q28389946 | Cancer evolution and individual susceptibility |
| Q26849726 | Candidate gene-environment interactions in breast cancer |
| Q34515023 | Caution in generalizing known genetic risk markers for breast cancer across all ethnic/racial populations |
| Q36030354 | Characterization of gene-environment interactions for colorectal cancer susceptibility loci |
| Q31149230 | Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells |
| Q89008777 | Cohort Profile: the Million Women Study |
| Q34736112 | Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer |
| Q47703662 | Common Genetic Variation and Breast Cancer Risk - Past, present, and future |
| Q51133919 | Correlations of common polymorphism of EVI-1 gene targeted by miRNA-206/133b with the pathogenesis of breast cancer. |
| Q35056542 | Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case-control study in Japanese women |
| Q38722531 | Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205. |
| Q34670325 | Emerging Concepts in Breast Cancer Risk Prediction |
| Q42869013 | Empirical evaluation of gene and environment interactions: methods and potential |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q44643445 | Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer |
| Q37690765 | Gene-Environment Interactions in Preventive Medicine: Current Status and Expectations for the Future |
| Q26772236 | Gene-environment interaction and risk of breast cancer |
| Q36661778 | Gene-environment interactions for breast cancer risk among Chinese women: a report from the Shanghai Breast Cancer Genetics Study |
| Q24289531 | Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report |
| Q84551204 | Genes, the environment, and breast cancer |
| Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
| Q34367710 | Genetic predisposition, parity, age at first childbirth and risk for breast cancer |
| Q37225586 | Genetic variants in lncRNA SRA and risk of breast cancer |
| Q38320144 | Human MCS5A1 candidate breast cancer susceptibility gene FBXO10 is induced by cellular stress and correlated with lens epithelium-derived growth factor (LEDGF). |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q36017113 | Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases |
| Q36249029 | Interaction between common breast cancer susceptibility variants, genetic ancestry, and nongenetic risk factors in Hispanic women |
| Q89866318 | Interactions between a Polygenic Risk Score and Non-genetic Risk Factors in Young-Onset Breast Cancer |
| Q40071035 | Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium |
| Q35166701 | Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium |
| Q34314805 | Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q57149115 | LINC00673 rs11655237 Polymorphism Is Associated With Increased Risk of Cervical Cancer in a Chinese Population |
| Q37644904 | Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells |
| Q51717530 | Missing heritability, next-generation genome-wide association studies and primary cancer prevention: an Atlantean illusion? |
| Q38415320 | Molecular epidemiology, and possible real-world applications in breast cancer |
| Q35902855 | No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels |
| Q47985043 | PPARγ and PPARGC1B polymorphisms modify the association between phthalate metabolites and breast cancer risk |
| Q51698938 | Personalizing prophylactic surgery in cancer: current practice and future perspectives from new genome-wide association studies. |
| Q34155371 | Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women |
| Q97423797 | Predicting breast cancer risk using interacting genetic and demographic factors and machine learning |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q57266562 | Prevention of breast cancer in the context of a national breast screening programme |
| Q30251394 | Putting the Genome in Context: Gene-Environment Interactions in Type 2 Diabetes |
| Q36405813 | Rat Mcs1b is concordant to the genome-wide association-identified breast cancer risk locus at human 5q11.2 and MIER3 is a candidate cancer susceptibility gene |
| Q37854021 | Redefining disease |
| Q35456134 | Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study |
| Q36245573 | Reproductive aging-associated common genetic variants and the risk of breast cancer |
| Q30251624 | Review of the Gene-Environment Interaction Literature in Cancer: What Do We Know? |
| Q49911416 | Screening for gene-environment (G×E) interaction using omics data from exposed individuals: an application to gene-arsenic interaction. |
| Q38909514 | TGF-β Regulates Survivin to Affect Cell Cycle and the Expression of EGFR and MMP9 in Glioblastoma |
| Q34985004 | TGF-β signaling in breast cancer cell invasion and bone metastasis |
| Q27021750 | Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy |
| Q37665532 | The LSP1 rs3817198 T > C polymorphism contributes to increased breast cancer risk: a meta-analysis of twelve studies |
| Q37237634 | The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk |
| Q57131263 | The benefits and harms of breast cancer screening: an independent review |
| Q36925187 | The genetics of breast cancer: risk factors for disease |
| Q39403309 | The polymorphisms in the MGMT gene and the risk of cancer: a meta-analysis |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Search more.